Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vicarious Surgical ( (RBOT) ) just unveiled an update.
On January 9, 2026, Vicarious Surgical Inc. held a special meeting of stockholders at which holders of Class A and Class B common stock, representing approximately 78.18% of the company’s total voting power, formed a quorum to vote on a single proposal. Stockholders overwhelmingly approved the exercise of warrants issued on October 7, 2025 to purchase up to an aggregate of 2,300,000 shares of Class A common stock, a step that positions the company to potentially strengthen its capital base and financial flexibility as it advances its surgical robotics business.
The most recent analyst rating on (RBOT) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.
Spark’s Take on RBOT Stock
According to Spark, TipRanks’ AI Analyst, RBOT is a Neutral.
The score is driven primarily by very weak financial performance (no revenue, heavy losses, significant cash burn, and sharply reduced equity). Technicals are also bearish with the stock below key moving averages and negative MACD. These are only partially offset by a somewhat better earnings-call outlook focused on expense reduction and improved cash burn guidance; valuation support is limited given ongoing losses and no dividend.
To see Spark’s full report on RBOT stock, click here.
More about Vicarious Surgical
Vicarious Surgical Inc. operates in the medical technology sector, developing and commercializing surgical robotics systems designed to enhance minimally invasive procedures for hospitals and healthcare providers.
Average Trading Volume: 130,774
Technical Sentiment Signal: Sell
Current Market Cap: $18.01M
See more insights into RBOT stock on TipRanks’ Stock Analysis page.